Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba, Tsukuba.
Department of Public Health, Hokkaido University Graduate School of Medicine, Sapporo.
J Hypertens. 2019 Jul;37(7):1366-1371. doi: 10.1097/HJH.0000000000002073.
To examine the association of blood pressure (BP) with cardiovascular mortality in real-world settings and investigate whether that association varied by use of antihypertensive medication at baseline.
Data from 27 728 Japanese men and women, aged 40-79 years, free of stroke, coronary heart disease, cancer, and kidney disease at entry (1988-1990) were used in this study. Mortality surveillance was completed through 2009, resulting in 449 800 person-years of follow-up. Hazard ratios for cardiovascular mortality were analysed by BP category (based on 2018 European guidelines) at admission.
There were 1477 deaths from cardiovascular diseases (CVDs). Relative to high-normal BP at admission, the multivariable hazard ratios (95% confidence intervals) of CVD were 0.85 (0.69-1.04) for optimal BP; 0.96 (0.81-1.15) for normal BP; 1.26 (1.09-1.46) for Grade 1 hypertension; and 1.55 (1.31-1.84) for Grade 2-3 hypertension. A similar linear association was observed among persons not taking antihypertensive medication at admission. Among patients treated for hypertension, a U-shaped association with CVD mortality was observed; hazard ratios = 2.31 (1.25-4.27), 1.68 (1.05-2.69), 1.56 (1.10-2.22), and 1.63 (1.13-2.36), respectively. Similar patterns were observed for stroke and coronary heart disease, although not always statistically significant.
BP categories at baseline were linearly and positively associated with CVD mortality overall and also among participants not taking antihypertensive medication. A higher risk of mortality from CVD was observed among patients already treated for hypertension with optimal and normal BPs than those with high-normal BP, suggesting the importance of careful monitoring of BP and comorbidities of such patients.
在真实环境中研究血压(BP)与心血管死亡率之间的关系,并探讨这种关系是否因基线时使用降压药物而有所不同。
本研究使用了 27728 名年龄在 40-79 岁、无卒中、冠心病、癌症和肾病的日本男性和女性的数据,这些人在入组时(1988-1990 年)没有这些疾病。通过 2009 年的死亡率监测,完成了 449800 人年的随访。根据入院时(2018 年欧洲指南)的 BP 分类,分析心血管死亡率的危险比。
共发生 1477 例心血管疾病(CVDs)死亡。与入院时的高正常 BP 相比,最佳 BP 的多变量危险比(95%置信区间)为 0.85(0.69-1.04);正常 BP 为 0.96(0.81-1.15);1 级高血压为 1.26(1.09-1.46);2-3 级高血压为 1.55(1.31-1.84)。在入院时未服用降压药物的人群中也观察到了类似的线性关系。在接受高血压治疗的患者中,观察到与 CVD 死亡率呈 U 形关联;危险比分别为 2.31(1.25-4.27)、1.68(1.05-2.69)、1.56(1.10-2.22)和 1.63(1.13-2.36)。对于卒中与冠心病也观察到了相似的模式,尽管并非总是具有统计学意义。
基线时的 BP 分类与 CVD 死亡率呈线性正相关,在未服用降压药物的参与者中也是如此。与高正常 BP 相比,接受降压治疗的患者中,最佳 BP 和正常 BP 的 CVD 死亡率风险更高,这表明需要仔细监测这些患者的 BP 和合并症。